Company
Genvax
Next-Generation mRNA + Nanoparticle Vaccines for Animal Health
Also known as Genvax Technologies, GenVax Technologies, Inc.
- Business model
- B2B
- Headquarters
- Ames, Iowa, United States
- Legal name
- GENVAX TECHNOLOGIES, INC.
- genvax.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Genvax is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation RNA + nanoparticle vaccines for animal health.
Funding snapshot
- Total raised
- $9.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Seed extension2025-02-03
Funding rounds
- Seed extension
- 2025-02-03
- Round, 2024
- $3.4M2024-06-07, SEC form D sold, 9 investors
- Round, 2022
- $6.4M2022-06-02, SEC form D sold, 20 investors
Products
- Other
- mRNA + Nanoparticle Vaccines for Animal Health
- Web
- Next-Generation mRNA + Nanoparticle Vaccines
Loading relationship preview